189 Participants Needed

Digital Therapeutics for Vaping

Recruiting at 1 trial location
PC
EK
Overseen ByErin Kasson, MSW
Age: < 65
Sex: Any
Trial Phase: Phase 1
Sponsor: Washington University School of Medicine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to help young people quit vaping through a digital app called quitSTART, specifically adapted for vaping cessation. Participants will use a version of the app that includes a chatbot feature for personalized support and encouragement. The goal is to evaluate the effectiveness of this intervention in reducing vaping among teens and young adults. Those who currently vape, have a smartphone, and discuss quitting online or have health issues from vaping might be suitable for this study. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the opportunity to experience this innovative approach first.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on using a digital app to help quit vaping.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that the quitSTART mobile app, designed to help people stop smoking, is safe. The app offers tips and encouragement to quit smoking, with no reports of harm from its use.

Studies have found that the chatbot feature in the quitSTART app can increase motivation to quit vaping and smoking. These chatbots engage users through short, helpful conversations. They are also used in other tools to aid smoking cessation and are generally considered safe.

This trial is in the early stages, focusing on ensuring the app and chatbot are safe and comfortable for users. Since the app and chatbot are not drugs or medical devices, they lack the side effects associated with medications. Overall, evidence suggests that both the app and the chatbot feature are safe for users.12345

Why are researchers excited about this trial?

Researchers are excited about these digital therapies for vaping cessation because they introduce innovative methods in supporting young adults to quit vaping. Unlike traditional options, which often involve counseling or nicotine replacement therapies, the quitSTART Mobile Application offers a mobile-based approach. Particularly, the experimental version includes an embedded chatbot feature that provides personalized, real-time support and motivation, making it more engaging and accessible. This tech-driven approach leverages the widespread use of smartphones among young adults, providing a potentially more effective and convenient resource for quitting vaping.

What evidence suggests that this trial's treatments could be effective for vaping cessation?

Research has shown that digital tools like the quitSTART mobile app can help people quit smoking, and similar success is expected for quitting vaping. In this trial, participants in Experimental Group A will use the quitSTART Mobile Application adapted for vaping cessation. Participants in Experimental Group B will use the same app with an embedded chatbot feature. The app provides personalized tips and encouragement based on smoking or vaping habits. Studies have found that customized digital tools, like quitSTART, keep users engaged and support their efforts to quit. The app also includes a chatbot feature to boost motivation and provide helpful content. This method is especially promising for young adults who seek privacy and support through their phones.678910

Are You a Good Fit for This Trial?

This trial is for U.S. residents who speak English, use vaping products daily, and have a smartphone. Participants should be networking about quitting or facing health issues from vaping but not using it to quit smoking.

Inclusion Criteria

You are a US resident.
You possess daily access to a smartphone.
You have used a vaping product within the past 30 days.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage with a mobile app intervention adapted for vaping cessation, including an embedded chatbot feature to guide and motivate cessation efforts

6 weeks
Online engagement

Follow-up

Participants are monitored for vaping cessation and engagement with the intervention

3 months
Online follow-up assessments

What Are the Treatments Tested in This Trial?

Interventions

  • Chatbot Feature in quitSTART Mobile Application
  • quitSTART Mobile Application
Trial Overview The study tests the quitSTART mobile app with an added chatbot feature designed to help teens and young adults stop vaping by providing tailored content and motivation through their smartphones.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Experimental Group B: Mobile App Intervention with Embedded Chatbot FeatureExperimental Treatment2 Interventions
Group II: Experimental Group A: Mobile App InterventionExperimental Treatment1 Intervention
Group III: Control GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Washington University School of Medicine

Lead Sponsor

Trials
2,027
Recruited
2,353,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+

The University of Texas Health Science Center, Houston

Collaborator

Trials
974
Recruited
361,000+

University of South Carolina

Collaborator

Trials
233
Recruited
122,000+

Citations

Identifying Patterns of Smoking Cessation App Feature Use ...The outcome of interest for this study, short-term cigarette smoking cessation, was measured at the end of the quitSTART EMA Incentivization ...
Identifying Patterns of Smoking Cessation App Feature Use ...Objective This study aimed to examine the influence of app-based EMA participation on smoking cessation for people who are incentivized to use ...
(PDF) Using Digital Technologies to Reach Tobacco Users ...In addition to the commercial options, the National Cancer Institute created two free SCAs (QuitGuide and quitSTART) integrated with their Smokefree.gov ...
An analysis of user assessments of the smoking cessation ...It is also promising that the quitSTART app data suggest that this smoking cessation app is perceived as highly usable among people from racial minority ...
12 Best Quit Smoking Apps for a Nicotine-Free 2025quitSTART excels at providing immediate, actionable support during moments of weakness. The app includes built-in games and challenges to ...
Conversational Chatbot for Cigarette Smoking CessationWe developed a quit smoking program spanning 42 days of 2- to 3-minute conversations covering topics ranging from motivations to quit, setting a quit date, ...
Interactive Conversational Agents for Cigarette-Smoking ...Our review found that compared to other smoking cessation methods, chatbots can lead to increased willingness to quit smoking and vaping, better engagement in ...
Co-Designing a Smoking Cessation Chatbot: Focus Group ...Our prototype smoking cessation chatbot, Quin, provides evidence-based, personalized support delivered via a smartphone app to help people quit ...
Fred Hutch launches free AI-powered chatbot app to help ...QuitBot is a comprehensive app that uses an AI-powered chatbot to provide users personalized support to quit smoking.
quitSTART Quit Smoking AppThe quitSTART app is a free smartphone app that helps you quit smoking with tailored tips, inspiration, and challenges.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security